Skip to main content
Erschienen in: Cancer Causes & Control 8/2009

01.10.2009 | Original Paper

Multivitamin use among multi-ethnic, low-income adults

verfasst von: Rachel C. Shelton, Elaine Puleo, Sapna Syngal, Karen M. Emmons

Erschienen in: Cancer Causes & Control | Ausgabe 8/2009

Einloggen, um Zugang zu erhalten

Abstract

There has been growing interest in the protective health benefits of multivitamin use (MVU). Relatively little research has investigated the factors associated with MVU among adults across a broad age range, particularly among lower-income, racially/ethnically diverse adults. In light of standing MVU recommendations and documented health benefits for certain groups, as well as ongoing studies evaluating the potential health benefits of multivitamins, vitamin D, and calcium, research among this understudied population is warranted. The aims of this paper were to assess the association between MVU and (1) sociodemographic, (2) preventive/health, and (3) patient/provider factors among a racially and ethnically diverse adult sample of over 1,500 low-income housing residents living in Boston, Massachusetts (USA). Bivariate and multivariable logistic regression models were the primary analytic strategy for investigating these associations. In multivariable analyses, sociodemographic factors (female gender, older age, and White or Other race/ethnicity) were significantly associated with regular MVU (p ≤ .05). Preventive/health variables (health status, physical activity, and body mass index) and characteristics of patient/provider relationships (having a regular provider, last provider visit, decision-autonomy, and quality of relationship) were not significantly associated with MVU. While more evidence is needed to understand the benefits of MVU, future studies should address low use of MVU among lower-income, multi-ethnic populations, particularly in light of health disparities.
Literatur
1.
Zurück zum Zitat Huang HY, Caballero B, Chang S, Alberg AJ, Semba RD, Schneyer CR et al (2006) The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a national institutes of health state-of-the-science conference. Ann Intern Med 145:372–385PubMed Huang HY, Caballero B, Chang S, Alberg AJ, Semba RD, Schneyer CR et al (2006) The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a national institutes of health state-of-the-science conference. Ann Intern Med 145:372–385PubMed
7.
Zurück zum Zitat McCullough ML, Robertson AS, Rodriguez C, Jacobs EJ, Chao A, Carolyn J et al (2003) Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition Cohort (United States). Cancer Causes Control 14:1–12. doi:10.1023/A:1022591007673 PubMedCrossRef McCullough ML, Robertson AS, Rodriguez C, Jacobs EJ, Chao A, Carolyn J et al (2003) Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition Cohort (United States). Cancer Causes Control 14:1–12. doi:10.​1023/​A:​1022591007673 PubMedCrossRef
8.
Zurück zum Zitat Huang H, Caballero B, Chang S, Alberg AJ, Semba RD, Schneyer C et al (2007) Multivitamin/mineral supplements and prevention of chronic disease: executive summary. Am J Clin Nutr 85(suppl):265S–268SPubMed Huang H, Caballero B, Chang S, Alberg AJ, Semba RD, Schneyer C et al (2007) Multivitamin/mineral supplements and prevention of chronic disease: executive summary. Am J Clin Nutr 85(suppl):265S–268SPubMed
9.
11.
Zurück zum Zitat McKay DL, Perrone G, Rasmussen H, Dallal G, Blumberg JB (2000) Multivitamin/mineral supplementation improves plasma B-vitamin status and homocysteine concentration in healthy older adults consuming a folate-fortified diet. J Nutr 130(12):3090–3096PubMed McKay DL, Perrone G, Rasmussen H, Dallal G, Blumberg JB (2000) Multivitamin/mineral supplementation improves plasma B-vitamin status and homocysteine concentration in healthy older adults consuming a folate-fortified diet. J Nutr 130(12):3090–3096PubMed
15.
Zurück zum Zitat Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, Picciano MF (2004) Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999–2000. Am J Epidemiol 160:339–349. doi:10.1093/aje/kwh207 PubMedCrossRef Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, Picciano MF (2004) Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999–2000. Am J Epidemiol 160:339–349. doi:10.​1093/​aje/​kwh207 PubMedCrossRef
16.
18.
Zurück zum Zitat Catov JM, Bodnar LM, Ness RB, Markovic N, Roberts JM (2007) Association of periconceptional multivitamin use and risk of preterm or small-for-gestational-age births. Am J Epidemiol 166(3):296–303. doi:10.1093/aje/kwm071 PubMedCrossRef Catov JM, Bodnar LM, Ness RB, Markovic N, Roberts JM (2007) Association of periconceptional multivitamin use and risk of preterm or small-for-gestational-age births. Am J Epidemiol 166(3):296–303. doi:10.​1093/​aje/​kwm071 PubMedCrossRef
19.
Zurück zum Zitat Pawlak R, Connell C, Brown D, Meyer MK, Yadrick K (2005) Predictors of multivitamin supplement use among African–American female students: a prospective study utilizing the theory of planned behavior. Ethn Dis 15(4):540–547PubMed Pawlak R, Connell C, Brown D, Meyer MK, Yadrick K (2005) Predictors of multivitamin supplement use among African–American female students: a prospective study utilizing the theory of planned behavior. Ethn Dis 15(4):540–547PubMed
21.
Zurück zum Zitat Jacobs EJ, Connell CJ, Patel AV, Chao A, Rodriguez C, Seymour J, McCullough ML, Calle EE, Thun MF (2001) Multivitamin use and colon cancer mortality in the Cancer Prevention Study II Cohort (United States). Cancer Causes Control 12:927–934. doi:10.1023/A:1013716323466 PubMedCrossRef Jacobs EJ, Connell CJ, Patel AV, Chao A, Rodriguez C, Seymour J, McCullough ML, Calle EE, Thun MF (2001) Multivitamin use and colon cancer mortality in the Cancer Prevention Study II Cohort (United States). Cancer Causes Control 12:927–934. doi:10.​1023/​A:​1013716323466 PubMedCrossRef
23.
Zurück zum Zitat Foote JA, Murphy SP, Wilkens LR, Hankin JH, Henderson BE, Kolonel LN (2003) Factors associated with dietary supplement use among healthy adults of five ethnicities: the Multiethnic Cohort Study. Am J Epidemiol 157:888–897. doi:10.1093/aje/kwg072 PubMedCrossRef Foote JA, Murphy SP, Wilkens LR, Hankin JH, Henderson BE, Kolonel LN (2003) Factors associated with dietary supplement use among healthy adults of five ethnicities: the Multiethnic Cohort Study. Am J Epidemiol 157:888–897. doi:10.​1093/​aje/​kwg072 PubMedCrossRef
25.
Zurück zum Zitat Kimmons JE, Blanck HM, Tohill BC, Zhang J, Khan LK (2006) Multivitamin use in relation to self-reported body mass index and weight loss attempts. Med Gen Med 8(3):3 Kimmons JE, Blanck HM, Tohill BC, Zhang J, Khan LK (2006) Multivitamin use in relation to self-reported body mass index and weight loss attempts. Med Gen Med 8(3):3
26.
Zurück zum Zitat Rock CL (2007) Multivitamin-multimineral supplements: who uses them? Am J Clin Nutr 85(suppl):277S–279SPubMed Rock CL (2007) Multivitamin-multimineral supplements: who uses them? Am J Clin Nutr 85(suppl):277S–279SPubMed
27.
Zurück zum Zitat Jasti S, Siega-Riz AM, Bentley ME (2003) Dietary supplement use in the context of health disparities: cultural, ethnic and demographic determinants of use. J Nutr 133(6):2010S–2013SPubMed Jasti S, Siega-Riz AM, Bentley ME (2003) Dietary supplement use in the context of health disparities: cultural, ethnic and demographic determinants of use. J Nutr 133(6):2010S–2013SPubMed
28.
Zurück zum Zitat Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M (2003) The women’s health initiative observational study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 13:S107–S121. doi:10.1016/S1047-2797(03)00047-4 PubMedCrossRef Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M (2003) The women’s health initiative observational study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 13:S107–S121. doi:10.​1016/​S1047-2797(03)00047-4 PubMedCrossRef
29.
Zurück zum Zitat O’Rourke KM, Roddy ME, Williams D, Mena K (2006) Predictors of early postpartum vitamin use among women of Mexican origin: implications for healthcare provider recommendations. Ethn Dis 16(1):194–200PubMed O’Rourke KM, Roddy ME, Williams D, Mena K (2006) Predictors of early postpartum vitamin use among women of Mexican origin: implications for healthcare provider recommendations. Ethn Dis 16(1):194–200PubMed
30.
Zurück zum Zitat Greenlee H, White E, Patterson RE, Kristal AR (2004) Supplement use among cancer survivors in the Vitamins and Lifestyle (VITAL) study cohort. J Altern Complement Med 10(4):660–666PubMed Greenlee H, White E, Patterson RE, Kristal AR (2004) Supplement use among cancer survivors in the Vitamins and Lifestyle (VITAL) study cohort. J Altern Complement Med 10(4):660–666PubMed
33.
Zurück zum Zitat McNeill LH, Puleo E, Bennett GG, Emmons KM (2007) Exploring social contextual correlates of computer ownership and frequency of use among urban, low-income, public housing adult residents. J Med Internet Res 9(4):e35. doi:10.2196/jmir.9.4.e35 PubMedCrossRef McNeill LH, Puleo E, Bennett GG, Emmons KM (2007) Exploring social contextual correlates of computer ownership and frequency of use among urban, low-income, public housing adult residents. J Med Internet Res 9(4):e35. doi:10.​2196/​jmir.​9.​4.​e35 PubMedCrossRef
34.
Zurück zum Zitat Emmons KM, Stoddard AM, Fletcher R, Gutheil C, Suarez EG, Lobb R, Weeks J, Bigby JA (2005) Cancer prevention among working class, multiethnic adults: results of the healthy directions-health centers study. Am J Public Health 95(7):1200–1205. doi:10.2105/AJPH.2004.038695 PubMedCrossRef Emmons KM, Stoddard AM, Fletcher R, Gutheil C, Suarez EG, Lobb R, Weeks J, Bigby JA (2005) Cancer prevention among working class, multiethnic adults: results of the healthy directions-health centers study. Am J Public Health 95(7):1200–1205. doi:10.​2105/​AJPH.​2004.​038695 PubMedCrossRef
38.
40.
Zurück zum Zitat Cleves MA, Hobbs CA, Collins HB, Andrews N, Smith LN, Robbins JM (2004) Folic acid use by women receiving routine gynecologic care. Obstet Gynecol 103:746–753PubMed Cleves MA, Hobbs CA, Collins HB, Andrews N, Smith LN, Robbins JM (2004) Folic acid use by women receiving routine gynecologic care. Obstet Gynecol 103:746–753PubMed
41.
Zurück zum Zitat March of Dimes (2000) Folic acid and the prevention of birth defects. A national survey of pre-pregnancy awareness and behavior among women of childbearing age 1995–2000. Conducted by the Gallup Organization. March of Dimes, White Plains (NY) March of Dimes (2000) Folic acid and the prevention of birth defects. A national survey of pre-pregnancy awareness and behavior among women of childbearing age 1995–2000. Conducted by the Gallup Organization. March of Dimes, White Plains (NY)
42.
Zurück zum Zitat Giovannucci E, Stampfer MJ, Colditz GA et al (1998) Multivitamin use, folate, and colon cancer in women in the Nurses’ Health Study. Ann Intern Med 129:517–524PubMed Giovannucci E, Stampfer MJ, Colditz GA et al (1998) Multivitamin use, folate, and colon cancer in women in the Nurses’ Health Study. Ann Intern Med 129:517–524PubMed
47.
Metadaten
Titel
Multivitamin use among multi-ethnic, low-income adults
verfasst von
Rachel C. Shelton
Elaine Puleo
Sapna Syngal
Karen M. Emmons
Publikationsdatum
01.10.2009
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 8/2009
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-009-9340-0

Weitere Artikel der Ausgabe 8/2009

Cancer Causes & Control 8/2009 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.